GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » Sale Of Investment

DLB (Dolby Laboratories) Sale Of Investment : $392 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Dolby Laboratories Sale Of Investment?

Dolby Laboratories's sale of investment for the three months ended in Sep. 2024 was $247 Mil. It means Dolby Laboratories gained $247 Mil from selling investments. Dolby Laboratories's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was $392 Mil.

Compared with last quarter ($43 Mil in Jun. 2024 ), Dolby Laboratories gained more money from selling investments in Sep. 2024 ($247 Mil).

Dolby Laboratories Sale Of Investment Historical Data

The historical data trend for Dolby Laboratories's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories Sale Of Investment Chart

Dolby Laboratories Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 491.14 64.79 118.01 231.80 391.79

Dolby Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.35 42.49 59.43 43.38 246.50

Dolby Laboratories Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $392 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dolby Laboratories Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Dolby Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » Sale Of Investment
Comparable Companies
AMTM ARMK ULS MMS CBZ UNF ABM FA AZZ CMPR CTAS LSE:REL TSX:TRI CPRT XAMS:WKL GPN TSX:RBA ASX:BXB LSE:RTO XPAR:SW
Traded in Other Exchanges
FUO:Germany FUO:Germany
Address
1275 Market Street, San Francisco, CA, USA, 94103-1410
Website
https://www.dolby.com
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.
Executives
Kevin J Yeaman officer: VP, Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Ryan Nicholson officer: VP, Corporate Controller C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling officer: SVP, Entertainment C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher director
Mark Andrew Sherman officer: EVP, GEN. COUN. & SECRTY DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton officer: SVP, Chief Marketing Officer 1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud director C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian director DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar officer: SVP, Advanced Technology Group C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet director 9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park officer: SVP & Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay officer: Sr. Vice President, Research 1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew officer: EVP, Chief Financial Officer DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103